Posts are written by library staff and reflect their personal opinions not necessarily those of MSK.
MSK Library’s physical space will be closed on Monday, January 18 and our virtual services will be offline in observance of Martin Luther King Jr.’s Birthday.
We will be back online on Tuesday, January 19. Learn more about our virtual services. You can also schedule a reservation to visit us in person on Mondays and Thursdays.
Experienced Pubmed users are enjoying the convenience of saving their search strategies and search results to their personal My NCBI accounts. We have promoted the use of these accounts and explained their features in previous blog posts.
In June 2021 the change will come to how the users log in to their personal My NCBI account. The National Library of Medicine stated its concern for user privacy as the reason for the coming change. The users will no longer be able to log in their My NCBI account with their “NCBI-managed credentials”, i.e. username and password they created specifically for MY NCBI account access.
The detailed instruction on how to change the way you log in to My NCBI using your linked accounts such as Google (your gmail credentials) and their credentials (called “federated account credentials”) can be found in the National Library of Medicine publication called NLM Technical Bulletin.
Once you have linked your account you can then log in to My NCBI using the linked account credentials. Click on Log In button in the right upper corner on the Pubmed page
and you will be prompted with a screen similar to the one below (depending on what account you would choose to link):
Enjoy using My NCBI!
The United States is behind its stated goals of vaccinating the population. This has inspired conversations about how and whether to stretch the vaccine supply to reach more people more quickly. In an opinion piece for STAT, MSK’s Dr. Peter B. Bach presents these questions as opportunities for further research.
Dr. Peter B. Bach, Director, Center for Health Policy and Outcomes.
Dr. Bach proposes that non-profit academic health centers administer the first dose of the Moderna or Pfizer vaccines to staff members, then give them the opportunity to opt into a randomized study. Participants would either receive the second dose as scheduled or a placebo. Researchers would follow the participants to see whether rates of infection differed starting one week after the second injection. Participants who received the placebo would get the second dose once the infection rates differed, allowing further data on the effectiveness of delaying the second dose.
Have questions about COVID vaccines? Dr. Elizabeth Robilotti offers answers on the MSK website.